Ep. 634 Heart Disease Risk, Lipids, and Imaging |Menopause, Perimenopause, Heart Health

Welcome to this week’s Midlife Minute episode!

Statistically, one in three women will die of heart disease. So, today, we’re answering some of the many questions I received about lipids and heart health. Although I’ve done other lipid-focused Midlife Minutes before, this episode is yet another dedicated to Dr. Tom Dayspring, as I’ve received such a vast number of questions on this particular topic.   

IN THIS EPISODE, YOU WILL LEARN:

Why understanding your ApoB and Lp(a) is an essential part of assessing your cardiovascular risk

Why treatments for lipid abnormalities should be individualized to fit each specific abnormality 

Essential lifestyle measures for supporting overall cardiovascular health

How CAC scoring, CT coronary angiography, and Clearly AI-assisted imaging differ, what each test measures, and their limitations 

How cardiovascular disease can sometimes present differently in women 

Why are premature atrial contractions and premature ventricular contractions often benign when the heart is structurally normal?

How the roles of statins, ezetimibe, PCSK9 inhibitors, GLP-1 medications, and emerging RNA therapies differ, and why they should not be considered interchangeable

How declining estrogen impacts cardiovascular health

Connect with Cynthia Thurlow